DK2041308T3 - Fremgangsmåde til detektion og diagnosticering af cancer, som involverer primere og prober til den specifikke detektion af MAGE-A3-markøren - Google Patents

Fremgangsmåde til detektion og diagnosticering af cancer, som involverer primere og prober til den specifikke detektion af MAGE-A3-markøren

Info

Publication number
DK2041308T3
DK2041308T3 DK07786793.5T DK07786793T DK2041308T3 DK 2041308 T3 DK2041308 T3 DK 2041308T3 DK 07786793 T DK07786793 T DK 07786793T DK 2041308 T3 DK2041308 T3 DK 2041308T3
Authority
DK
Denmark
Prior art keywords
detection
mage
probes
marker
diagnosis
Prior art date
Application number
DK07786793.5T
Other languages
English (en)
Inventor
Thierry Coche
Olivier Gruselle
Gabriele Anne-Marie Beer
Dennis Salonga
Craig Lawrence Stephens
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Application granted granted Critical
Publication of DK2041308T3 publication Critical patent/DK2041308T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0091—Purification or manufacturing processes for gene therapy compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Manufacturing & Machinery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK07786793.5T 2006-06-21 2007-06-21 Fremgangsmåde til detektion og diagnosticering af cancer, som involverer primere og prober til den specifikke detektion af MAGE-A3-markøren DK2041308T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0612342.6A GB0612342D0 (en) 2006-06-21 2006-06-21 Method
PCT/EP2007/056219 WO2007147876A2 (en) 2006-06-21 2007-06-21 Method for the detection and diagnosis of cancer involving primers and probes for the specific detection of the mage- a3 -marker

Publications (1)

Publication Number Publication Date
DK2041308T3 true DK2041308T3 (da) 2012-10-08

Family

ID=36803668

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07786793.5T DK2041308T3 (da) 2006-06-21 2007-06-21 Fremgangsmåde til detektion og diagnosticering af cancer, som involverer primere og prober til den specifikke detektion af MAGE-A3-markøren

Country Status (28)

Country Link
US (1) US8936919B2 (da)
EP (1) EP2041308B1 (da)
JP (2) JP2009540812A (da)
KR (1) KR101455589B1 (da)
CN (1) CN101506383B (da)
AU (1) AU2007263019B2 (da)
BR (1) BRPI0713599A2 (da)
CA (1) CA2656909A1 (da)
CO (1) CO6140072A2 (da)
CY (1) CY1113290T1 (da)
DK (1) DK2041308T3 (da)
EA (1) EA016347B1 (da)
ES (1) ES2389513T3 (da)
GB (1) GB0612342D0 (da)
HK (1) HK1127627A1 (da)
HR (1) HRP20120761T1 (da)
IL (1) IL195975A (da)
MA (1) MA30565B1 (da)
MX (1) MX2008016493A (da)
MY (1) MY147511A (da)
NO (1) NO20085290L (da)
NZ (1) NZ573809A (da)
PL (1) PL2041308T3 (da)
PT (1) PT2041308E (da)
SI (1) SI2041308T1 (da)
UA (1) UA95956C2 (da)
WO (1) WO2007147876A2 (da)
ZA (1) ZA200810695B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009037438A1 (en) * 2007-09-17 2009-03-26 Oncomethylome Sciences Sa Improved detection of mage-a expression
WO2012010635A1 (en) * 2010-07-22 2012-01-26 Glaxosmithkline Biologicals S.A. Novel antigen binding proteins
CN102251033B (zh) * 2011-07-05 2013-03-20 北京大学人民医院 基于mage-a3基因辅助诊断多发性骨髓瘤患者的定量检测试剂盒

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612201A (en) * 1991-05-23 1997-03-18 Ludwig Institute For Cancer Research Isolated nucleic acid molecules useful in determining expression of a tumor rejection antigen precursor
CA2141960A1 (en) * 1992-08-07 1994-02-17 Ralph T. Kubo Hla binding peptides and their uses
WO1995023874A1 (en) * 1994-03-01 1995-09-08 Ludwig Institute For Cancer Research Determination of cancerous conditions by mage gene expression
US5985571A (en) 1998-02-04 1999-11-16 Ludwig Institute For Cancer Research Method for determining multiple myeloma by assaying for expression of mage genes
SI1659178T1 (sl) * 1998-02-05 2010-07-30 Glaxosmithkline Biolog Sa Postopek za čiščenje ali proizvodnjo MAGE proteina
WO2000020445A2 (en) * 1998-10-02 2000-04-13 Ludwig Institute For Cancer Research Tumor antigens and ctl clones isolated by a novel procedure
JP3603138B2 (ja) * 2000-02-18 2004-12-22 独立行政法人理化学研究所 細胞死抑制タンパク質
US6358679B1 (en) * 2000-08-24 2002-03-19 Pe Corporation (Ny) Methods for external controls for nucleic acid amplification
US6635425B2 (en) 2001-01-05 2003-10-21 Molecular Staging, Inc. 5′-thio phosphate directed ligation of oligonucleotides and use in detection of single nucleotide polymorphisms
AU2002365291B2 (en) * 2001-11-29 2007-11-01 Dandrit Biotech A/S Pharmaceutical composition for inducing an immune response in a human or animal
EP1572105B1 (en) * 2002-11-14 2011-08-31 John Wayne Cancer Institute Detection of micro metastasis of melanoma and breast cancer in paraffin-embedded tumor draining lymph nodes by multimaker quantitative rt-pcr
ATE517992T1 (de) 2002-11-14 2011-08-15 Dharmacon Inc Funktionelle und hyperfunktionelle sirna
GB0409940D0 (en) * 2004-05-04 2004-06-09 Glaxosmithkline Biolog Sa Vaccine
US20070231822A1 (en) * 2006-02-28 2007-10-04 Michael Mitas Methods for the detection and treatment of cancer

Also Published As

Publication number Publication date
KR101455589B1 (ko) 2014-10-28
JP2009540812A (ja) 2009-11-26
GB0612342D0 (en) 2006-08-02
PL2041308T3 (pl) 2012-11-30
HK1127627A1 (en) 2009-10-02
WO2007147876A2 (en) 2007-12-27
JP5705191B2 (ja) 2015-04-22
JP2013046630A (ja) 2013-03-07
AU2007263019A1 (en) 2007-12-27
IL195975A (en) 2012-08-30
CY1113290T1 (el) 2016-04-13
CA2656909A1 (en) 2007-12-27
IL195975A0 (en) 2009-09-01
CN101506383B (zh) 2013-08-28
US8936919B2 (en) 2015-01-20
UA95956C2 (uk) 2011-09-26
EP2041308A2 (en) 2009-04-01
CN101506383A (zh) 2009-08-12
EP2041308B1 (en) 2012-07-11
EA016347B1 (ru) 2012-04-30
HRP20120761T1 (hr) 2012-10-31
US20120040341A1 (en) 2012-02-16
BRPI0713599A2 (pt) 2012-11-06
SI2041308T1 (sl) 2012-10-30
EA200802356A1 (ru) 2009-06-30
CO6140072A2 (es) 2010-03-19
MY147511A (en) 2012-12-31
PT2041308E (pt) 2012-10-09
KR20090034900A (ko) 2009-04-08
MA30565B1 (fr) 2009-07-01
ZA200810695B (en) 2014-03-26
AU2007263019B2 (en) 2012-11-08
WO2007147876A3 (en) 2008-05-15
ES2389513T3 (es) 2012-10-26
NO20085290L (no) 2009-01-19
MX2008016493A (es) 2009-05-21
NZ573809A (en) 2011-12-22

Similar Documents

Publication Publication Date Title
DK3567363T3 (da) Prøvningsindretninger, -fremgangsmåder og reagenser
EP2170075A4 (en) MARKED INHIBITORS OF PROSTATE SPECIFIC MEMBRANEANT (PSMA), BIOLOGICAL ASSESSMENT AND USE AS IMAGING AGENT
DK2371958T3 (da) HIDTIL UKENDTE siRNA OG FREMGANGSMÅDER TIL ANVENDELSE DERAF
DK3461503T3 (da) Fremgangsmåder til indgivelse af tetrahydrobiopterin, associerede sammensætninger og målingsfremgangsmåder
BRPI0818801A2 (pt) Sistema de testes de diagnóstico.
BRPI0814320A2 (pt) Método para determinar automaticamente o estado de uso de um dispositivo médico eletrônico e/ou ativar dito dispositivo médico eletrônico, e, estetoscópio eletrônico.
WO2008039769A3 (en) Methods and devices for analyzing small rna molecules
DK2155188T3 (da) Fremgangsmåder og sammensætninger til behandling af tilbagevendende kræft
BRPI1010798A2 (pt) fechamento, aparelho de retenção, e método de uso do mesmo
BRPI0819819A2 (pt) Preparações, método e kits ùteis para o tratamento de tosse
DK2209375T3 (da) Parp-inhibitorforbindelser, præparater og fremgangsmåder til anvendelse deraf
EP2150625A4 (en) METHODS, COMPOSITIONS AND KITS FOR DETECTION AND ANALYSIS OF ANTIBIOTIC RESISTANT BACTERIA
DK1988090T3 (da) Imidazol-5-carboxylsyrederivater, fremgangsmåder til fremstilling af disse og anvendelse deraf
BRPI1008534A2 (pt) aparelho e métodos para testar fluido de furo de poço
DE602006000297D1 (de) Verbinder , Verbinderprüfgerät und Verfahren
BRPI0814330A2 (pt) métodos e kits cirúrgicos
BRPI0910030A2 (pt) método de teste ultra-sônico e equipamento para o mesmo.
DK2617714T3 (da) Kemiske derivater af jasmonat, farmaceutiske præparater og fremgangsmåder til anvendelse deraf
BRPI0718850A2 (pt) Métodos de tratar, diagnosticar ou detectar câncer
DK2021794T3 (da) Anvendelse af protein S100A 12 som en markør for colorektal cancer
NO20083908L (no) Fluidanalysesystem og metode for drift av et analysesystem
FR2896069B1 (fr) Dispositif de tele-releve de compteurs de fluide.
ZA200808669B (en) Methods of treating, diagnosing or detecting cancer
DK1976884T3 (da) Anti-ephrinb2-antistoffer og fremgangsmåder til anvendelse deraf.
EP2011871A4 (en) PRIMER AND PROBE FOR THE DETECTION OF MYCOBACTERIUM INTRACELLULARE AND METHOD FOR THE DETECTION OF MYCOBACTERIUM INTRACELLULARE USING THE PRIMER AND THE PROBE